(Q31711815)

3 July 2017

title

Melatonin secretion occurs at a constant rate in both young and older men and women (English)

1 reference

3 July 2017

0 references

Fourtillan JB

1

1 reference

3 July 2017

Brisson AM

2

1 reference

3 July 2017

Fourtillan M

3

1 reference

3 July 2017

Ingrand I

4

1 reference

3 July 2017

Decourt JP

5

1 reference

3 July 2017

Girault J

6

1 reference

3 July 2017

publication date

1 January 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

3 July 2017

published in

1 reference

3 July 2017

volume

280

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

E11-22

1 reference

Minimum light intensity required to suppress nocturnal melatonin concentration in human saliva.

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Photic regulation of melatonin in humans: ocular and neural signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

A mathematical model of diurnal variations in human plasma melatonin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Melatonin: generation and modulation of avian circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

The dim light melatonin onset as a marker for circadian phase position.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

The effect of dim light on suppression of nocturnal melatonin in healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Modulation of plasma melatonin concentrations by changes in posture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Melatonin: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Plasma melatonin as a measure of the human clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Neuroendocrine aspects of primary endogenous depression. XV: Mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Melatonin: pathway from obscure molecule to international fame

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Melatonin and seasonal rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

Do plasma melatonin concentrations decline with age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.280.1.E11

10.1152/AJPENDO.2001.280.1.E11

21 January 2018

Identifiers

DOI

0 references

1 reference